Search by Drug Name or NDC
NDC 00409-0152-24 Metronidazole 5 mg/mL Details
Metronidazole 5 mg/mL
Metronidazole is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is METRONIDAZOLE.
MedlinePlus Drug Summary
Metronidazole injection is used to treat certain skin, blood, bone, joint, gynecologic, and abdominal (stomach area) infections caused by bacteria. It is also used to treat endocarditis (infection of the heart lining and valves), meningitis (infection of the membranes that surround the brain and spinal cord), and certain respiratory infections, including pneumonia. Metronidazole injection is also to prevent infection when used before, during, and after colorectal surgery. Metronidazole injection is in a class of medications called antibacterials. It works by killing bacteria and protozoa that cause infection. Antibiotics such as metronidazole injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.infections of the respiratory tract, including bronchitis, pneumonia
Related Packages: 00409-0152-24Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Metronidazole Injection
Product Information
| NDC | 00409-0152 |
|---|---|
| Product ID | 0409-0152_3dc29403-f807-4e6a-835b-e6f26272fd6c |
| Associated GPIs | 16000035002030 |
| GCN Sequence Number | 009588 |
| GCN Sequence Number Description | metronidazole/sodium chloride PIGGYBACK 500MG/0.1L INTRAVEN |
| HIC3 | W4E |
| HIC3 Description | ANAEROBIC ANTIPROTOZOAL-ANTIBACTERIAL AGENTS |
| GCN | 43025 |
| HICL Sequence Number | 008259 |
| HICL Sequence Number Description | METRONIDAZOLE IN SODIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | Metronidazole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metronidazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | METRONIDAZOLE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206191 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-0152-24 (00409015224)
| NDC Package Code | 0409-0152-24 |
|---|---|
| Billing NDC | 00409015224 |
| Package | 24 POUCH in 1 CARTON (0409-0152-24) / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-0152-01) |
| Marketing Start Date | 2021-12-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |